chr11-66858540-C-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2

The NM_024036.5(LRFN4):​c.796C>T​(p.Arg266Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000796 in 1,381,564 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000080 ( 0 hom. )

Consequence

LRFN4
NM_024036.5 missense

Scores

9
6
4

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.65
Variant links:
Genes affected
LRFN4 (HGNC:28456): (leucine rich repeat and fibronectin type III domain containing 4) Predicted to be involved in regulation of postsynaptic density assembly; regulation of presynapse assembly; and synaptic membrane adhesion. Predicted to be located in plasma membrane. Predicted to be active in GABA-ergic synapse; cell surface; and glutamatergic synapse. Predicted to be integral component of postsynaptic density membrane. [provided by Alliance of Genome Resources, Apr 2022]
PC (HGNC:8636): (pyruvate carboxylase) This gene encodes pyruvate carboxylase, which requires biotin and ATP to catalyse the carboxylation of pyruvate to oxaloacetate. The active enzyme is a homotetramer arranged in a tetrahedron which is located exclusively in the mitochondrial matrix. Pyruvate carboxylase is involved in gluconeogenesis, lipogenesis, insulin secretion and synthesis of the neurotransmitter glutamate. Mutations in this gene have been associated with pyruvate carboxylase deficiency. Alternatively spliced transcript variants with different 5' UTRs, but encoding the same protein, have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.879
BS2
High AC in GnomAdExome4 at 11 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
LRFN4NM_024036.5 linkuse as main transcriptc.796C>T p.Arg266Cys missense_variant 1/2 ENST00000309602.5
PCNM_001040716.2 linkuse as main transcriptc.1369-5157G>A intron_variant ENST00000393960.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
LRFN4ENST00000309602.5 linkuse as main transcriptc.796C>T p.Arg266Cys missense_variant 1/21 NM_024036.5 P1
PCENST00000393960.7 linkuse as main transcriptc.1369-5157G>A intron_variant 5 NM_001040716.2 P1P11498-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.0000307
AC:
4
AN:
130096
Hom.:
0
AF XY:
0.0000422
AC XY:
3
AN XY:
71144
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000412
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000446
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000409
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000796
AC:
11
AN:
1381564
Hom.:
0
Cov.:
31
AF XY:
0.00000587
AC XY:
4
AN XY:
681510
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000282
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000379
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000557
Gnomad4 OTH exome
AF:
0.0000173
GnomAD4 genome
Cov.:
32
ExAC
AF:
0.0000104
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 21, 2024The c.796C>T (p.R266C) alteration is located in exon 1 (coding exon 1) of the LRFN4 gene. This alteration results from a C to T substitution at nucleotide position 796, causing the arginine (R) at amino acid position 266 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.69
BayesDel_addAF
Benign
-0.038
T
BayesDel_noAF
Benign
-0.16
CADD
Pathogenic
32
DANN
Uncertain
1.0
DEOGEN2
Benign
0.13
T;T
Eigen
Uncertain
0.48
Eigen_PC
Uncertain
0.32
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Pathogenic
0.99
D;D
M_CAP
Pathogenic
0.71
D
MetaRNN
Pathogenic
0.88
D;D
MetaSVM
Uncertain
-0.27
T
MutationAssessor
Pathogenic
3.3
.;M
MutationTaster
Benign
1.0
D;D;D;D;D;D
PrimateAI
Pathogenic
0.89
D
PROVEAN
Pathogenic
-7.1
D;D
REVEL
Uncertain
0.32
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0010
D;D
Polyphen
1.0
.;D
Vest4
0.77
MutPred
0.65
Gain of catalytic residue at A270 (P = 0.1469);Gain of catalytic residue at A270 (P = 0.1469);
MVP
0.54
MPC
2.5
ClinPred
0.97
D
GERP RS
3.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.69
gMVP
0.90

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs771499528; hg19: chr11-66626011; API